Journals / Gazi Medical Journal / 2016 / Cilt: 27 - Sayı: 3

Dejeneratif Aort Kapak Stenozu Varlığı ve Ciddiyeti ile Nötrofil-Lenfosit Oranı Arasındaki İlişki

Association of Neutrophil-Lymphocyte Ratio with the Presence and Severity of Degenerative Aortic Valve Stenosis

Pages
128–131
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The neutrophillymphocyte ratio was significantly higher in severe AS group than for the mild and moderate AS group (1.95±0.42, 2.31±0.69, 2.67±0.73; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In different studies, it has been shown that degenerative aortic stenosis and atherosclerosis had a common pathogenic mechanism.
📊
Key Findings & Data:Methods: Echocardiographic data (from May 2011 to September 2013) of our cardiology department was reviewed retrospectively.
💡
Conclusion & Impact:The neutrophillymphocyte ratio was significantly higher in severe AS group than for the mild and moderate AS group (1.95±0.42, 2.31±0.69, 2.67±0.73; p
🔬Design:Review & Systematic Survey
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In different studies, it has been shown that degenerative aortic stenosis and atherosclerosis had a common pathogenic mechanism. The goal of this study was to examine the association between NLR and the presence and severity of degenerative aortic valve stenosis. Methods: Echocardiographic data (from May 2011 to September 2013) of our cardiology department was reviewed retrospectively. After evaluation according to exclusion criteria's, a total of 103 patients with degenerative AS and a control group of 35 age- and gender- matched patients who had normal echocardiographic findings were included in the study. Results: The level of NLR was highest in severe AS. The neutrophillymphocyte ratio was significantly higher in severe AS group than for the mild and moderate AS group (1.95±0.42, 2.31±0.69, 2.67±0.73; p

Özet

Amaç: Farklı çalışmalarda dejeneratif aort darlığı ve aterosklerozun ortak bir patojenik mekanizmaya sahip olduğu gösterilmiştir. Bu çalışmanın amacı, NLR ile dejeneratif aort kapak darlığının varlığı ve ciddiyeti arasındaki ilişkiyi incelemekti. Gereç ve yöntemler : Kardiyoloji bölümünün ekokardiografik kayıtları ( mayıs 2011 ve eylül 2013 ) retrospektif olarak incelendi. Dışlanma kriterleri değerlendirildikten sonra 103 dejeneratif aort darlığı hastası ile normal ekokardiografik bulguları olan , yaş ve cinsiyet olarak eşleştirilmiş 35 hasta çalışmaya alındı. Bulgular : NLR seviyesi ciddi aort darlığı (AD) grubunda en yüksek bulundu. Nötrofil lenfosit oranı ciddi AD grubunda hafif ve orta aort darlığı gruplarına kıyasla daha yüksek saptandı(1,95±0,42 , 2,31±0,69 , 2,67±0,73; p< 0,001 sırasıyla).Tüm aort darlığı gruplarında NLR kontrol grubuna kıyasla yüksek saptandı.(p< 0,001). Ayrıca dejeneratif aort darlığı hastalarında transaortik pik basınç gradienti ile NLR arasında istatiksel olarak anlamlı bir korelasyon izlendi ( r : 0,626 , p < 0,001 ). Sonuç: Kronik enflamasyonun ucuz ve kolay ulaşılabilir bir göstergesi olan NLR ; dejeneratif aort darlığının varlığı ve ciddiyetini tahmin etmede kullanışlı bir rol oynayabilir.

🔖

Cite This Article

ONCEL, C. R., KUCUK, M., UCAR, M., AVCI, F. D., YİLDİRİM, A. B., YANIKOGLU, A. (2022). Dejeneratif Aort Kapak Stenozu Varlığı ve Ciddiyeti ile Nötrofil-Lenfosit Oranı Arasındaki İlişki. Gazi Medical Journal, Cilt: 27 - Sayı: 3, 128–131. https://ajindex.com/articles/519965

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: A disease of the valve and the myocardium. J Am Coll Cardiol. 2012;60:1854-63.
  2. Mazzone A, Epistolato MC, De Caterina R, Starti S, Vittorini S, Sbrana S, et al. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein- 60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. J Am Coll Cardiol. 2004, 43:1670-6.
  3. Rajamannan NM, Gersh B, Bonow RO. Calcific aortic stenosis: from bench to the bedside - emerging clinical and cellular concepts. Heart. 2003, 89:801-5.
  4. Freeman RV, Otto CM.Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005, 111:3316-6.
  5. Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013;11:55-9. Kaya MG. Inflammation and coronary artery disease: as a new biomarker neutrophil/lymphocyte ratio [in Turkish]. Turk Kardiyol Dern Ars. 2013;41:191-92.
  6. Losi MA, Brevetti G, Schiano V, Barbati G, Parisi V, Contaldi C, et al. Aortic valve sclerosis in patients with peripheral and/or coronary arterial disease. Echocardiography. 2010;27:608-12.
  7. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM, et al. Apolipoprotein B, (a), and E accumulate in the morphologically early lesion of degenerative valvular aortic stenosis. Arterioscler Thromb. 1996, 16:523-32.
  8. Helske S, Lindstedt KA, Laine M, Mayranpaa M, Werkkala K, Lommi J, et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J Am Coll Cardiol. 2004;44:1859-66.
  9. Pohle K, Maffert R, Ropers D, Moshage W, Stilianakis N, Daniel WG,et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation. 2001;104:1927- 32. O'Brien KD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol.2006;26:1721-8.
  10. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization nof the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation.1994;90:844-53.
  11. Gunduz H, Akdemir R, Binak E, Tamer A, Keser N, Uyan C, et al. Can serum lipid and CRP levels predict the "severity" of aortic valve stenosis? Acta Cardiol.2003, 58:321-6.
  12. Galante A, Pietroiusti A, Vellini M,